Clinical Trial Update: Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 trial comparing augmentation strategies (amantadine, pramipexole, and quetiapine) for treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Pramipexole (pramipexole)
• Quetiapine (quetiapine)
• amantadine (amantadine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Treatment Resistant Depression | Phase 4 | Status: UNKNOWN